Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Last Call for Cyber Monday! Save Now on Claim 60% OFF
Close

Athersys Inc (ATHX)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.0175 0.0000    0.00%
- Closed. Currency in USD ( Disclaimer )
After Hours
0.0170
-0.0005
-2.8571%
- Delayed Data
Type:  Equity
Market:  United States
  • Volume: 498,201
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0166 - 0.0198
Athersys 0.0175 0.0000 0.00%

Athersys Inc Company Profile

 
Get an in-depth profile of Athersys Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

24

Equity Type

ORD

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company’s lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.

Contact Information

Address 3201 Carnegie Avenue
Cleveland, 44115-2634
United States
Phone 216 431 9900
Fax 216 361 9495
Web www.athersys.com

Top Executives

Name Age Since Title
Gilbert Clincke - - Scientific and Clinical Advisor
Brian H. Annex - - Scientific and Clinical Advisor
Marc Steven Penn - - Scientific and Clinical Advisor
Michael Simons - - Scientific and Clinical Advisor
Warren Sherman 72 - Scientific and Clinical Advisor
Robert F. Kushner - - Scientific and Clinical Advisor
James G. Shook 83 2000 Scientific and Clinical Advisor
John Wagner - - Scientific & Clinical Advisor
Richard T. Maziarz - - Scientific & Clinical Advisor
F. Xavier Pi-Sunyer - - Scientific and Clinical Advisor
Larry Wechsler - - Scientific and Clinical Advisor
Hillard M. Lazarus - - Scientific & Clinical Advisor
Catherine Verfaillie - - Scientific and Clinical Advisor
C. Thomas Caskey 83 2000 Scientific and Clinical Advisor
David Hess - - Scientific and Clinical Advisor
Ira Mellman - - Scientific and Clinical Advisor
Jerry Silver - - Scientific and Clinical Advisor
Neema Mayhugh 47 2023 Independent Director
Joseph P. Nolan 60 2023 Independent Director
Jack L. Wyszomierski 67 2010 Independent Director
Jane Wasman 67 2020 Independent Chairman
Daniel A. Camardo 54 2022 CEO, Secretary & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ATHX Comments

Write your thoughts about Athersys Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Orhan Aptishev
Orhan Aptishev Oct 11, 2023 5:23AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
its gone to dust after todays news. good bye ATHX was nice knowing you
Reply
0 0
Report
Will Rok
hopeisnotinvest Aug 22, 2023 11:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
dilution over pps going higher
Reply
0 0
Report
Talha Aydın
Talha Aydın Aug 07, 2023 3:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
handed over
Reply
0 0
Report
Orhan Aptishev
Orhan Aptishev Aug 07, 2023 3:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i cant watch this anymore. have signed out of all my apps. will check again in 2024
Reply
1 0
Report
Talha Aydın
Talha Aydın Aug 07, 2023 3:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This makes people crazy
Reply
0 0
Report
Talha Aydın
Talha Aydın Aug 04, 2023 2:09PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No friend, how far will you fall, rise a little, get out a little, let's see some movement from you.
Reply
0 0
Report
Talha Aydın
Talha Aydın Jul 31, 2023 10:51AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
When do you think it will rise, Mr. Orhan?
Reply
1 0
Report
Orhan Aptishev
Orhan Aptishev Jul 31, 2023 10:51AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i think is looking for new bottom before the sale of stocks offering. after that price should rise as they are trying to maintain 35mil valuation to stay on Nasdaq. i think 50 cents is the lowest so anything between 50 and 70 cents for me personally is good but long term. Short term i am going bearish
Reply
0 0
Report
Talha Aydın
Talha Aydın Jul 28, 2023 2:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why are you falling so low
Reply
0 0
Report
Orhan Aptishev
Orhan Aptishev Jul 28, 2023 2:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i think they announced shares offering soon, that could explain it
Reply
0 0
Report
Talha Aydın
Talha Aydın Jul 28, 2023 2:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Do you think the latest situation balance sheet will give us a positive feedback?
Reply
0 0
Report
Orhan Aptishev
Orhan Aptishev Jul 28, 2023 2:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
its very likely but in short term i am little bearish on this. I set target for my plan aiming October. For now i just DCA on way down.
Reply
0 0
Report
Talha Aydın
Talha Aydın Jul 28, 2023 2:29PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I wish there was a shot for at least 1 dollar until September and October
Reply
0 0
Report
Orhan Aptishev
Orhan Aptishev Jul 26, 2023 8:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
aaaand it's gone 👌
Reply
0 0
Report
Talha Aydın
Talha Aydın Jul 18, 2023 3:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Does anyone have any hope for this, it still doesn't move up
Reply
1 0
Report
Orhan Aptishev
Orhan Aptishev Jul 18, 2023 3:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
looks like it did double bittom at .74 area and now moving towards 1$ area. 5.56 target long
Reply
0 0
Report
Talha Aydın
Talha Aydın Apr 27, 2023 9:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Let's sacrifice for more than 2 dollars
Reply
0 0
Report
Orhan Aptishev
Orhan Aptishev Apr 27, 2023 9:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
when 2 dollars?
Reply
1 0
Report
Talha Aydın
Talha Aydın Apr 21, 2023 4:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Do you think it will go over $1?
Reply
0 0
Report
Orhan Aptishev
Orhan Aptishev Apr 21, 2023 4:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this month will fluctuate a lot. probably will go above 1 briefly and pull back. to 90 cents. my orice target is 1.45 next month and half
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email